Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-18

Clinical Trial Update: Efficacy of Novel Drug-combinations for Relief of Psoriasis

View source ↗

Summary

Clinical trial NCT02394301 evaluating novel drug combinations for psoriasis has been suspended; no efficacy results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medimix Specialty Pharmacy, LLC | Conditions: Psoriasis | Status: SUSPENDED